Mode
Text Size
Log in / Sign up
N/A N=210

Physical Health in Midlife: Influences of Adversity and Relationships Over Time

Cardiovascular Disease · Type 2 Diabetes

Enrolled (actual)
210
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcome: Primary: Hormonal Levels — 910000; 5.8; 22.8; 171.8 ng/ml

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Adult · 35+ yrs
Sex
All
Sponsor
Beth Israel Deaconess Medical Center
Primary completion
May 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Hormonal Levels
910000; 5.8; 22.8; 171.8; 820000; 530000
PRIMARY
Psychosocial Adversity
3.24; 22.41; 2.47; 1.03
PRIMARY
Psychosocial Health Risk Factors Correlated With BMI
0.17; 0.23; -0.17; 0.14; 0.49; 0.45
PRIMARY
Social Adjustment Scale
2.47
SECONDARY
Body Mass Index (BMI)
30.41
SECONDARY
Health Risk Factors
1.33

Summary

The purpose of this study is to determine the effects of individual characteristics, life stresses, and relationships over time on psychosocial outcomes (e.g. marriage, parenting, work) and physical health

Eligibility Criteria

Inclusion Criteria

  • Male and female participants between 35 and 55 years of age.

Exclusion Criteria: (based on interference with key assessments)

  • Abnormal hepatic function (liver function tests >2X upper normal);
  • abnormal renal function (creatinine >1.3 mg/dl);
  • conditions/illnesses such as active infection, significant malabsorption/malnutrition, cancer;
  • active hormonal disease such as overt hypo/hyperthyroidism, hypogonadism, hyper-cortisolism, or treatment with steroids or growth hormone.
  • Known Diabetes Mellitus (DM) and Cardiovascular Disease (CVD) will be screened for by a detailed history and systems review.
  • Baseline laboratory analysis with chemistries, CBC, hormone levels, and EKG will be completed.

Two exceptions will be made to the usual exclusion criteria:

  • Original subjects with DM or CVD will not be excluded, since that would result in bias in that sample and loss of opportunity to examine predictors associated with these outcomes.
  • Community adults diagnosed with these disorders at the screening visit will be retained and referred for medical treatment as needed. In both groups, those with DM and/or CVD will be followed for psychosocial and relevant biomedical variables, excluding assessments interfered with by CVD and DM relevant medications. Those with DM and CVD will at times be separately analyzed, together with participants who develop these disorders in the years of this new study phase.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01853332). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search